AbbVie Inc (ABBV) Stock: What Does the Chart Say Monday?

Overall market sentiment has been high on AbbVie Inc (ABBV) stock lately. ABBV receives a Bullish rating from InvestorsObserver Stock Sentiment Indicator.

AbbVie Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on ABBV!

See Full ABBV Report

What is Stock Sentiment?

In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company. Recent trends are a good indicator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive. InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend. Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .

What's Happening With ABBV Stock Today?

AbbVie Inc (ABBV) stock has fallen -0.67% while the S&P 500 has gained 0.23% as of 1:48 PM on Monday, Aug 15. ABBV is down -$0.95 from the previous closing price of $142.60 on volume of 2,592,323 shares. Over the past year the S&P 500 is down -4.23% while ABBV has gained 19.63%. ABBV earned $7.07 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 20.05.

More About AbbVie Inc

AbbVie is a pharmaceutical company with a strong exposure to immunology and oncology. The firm's top drug, Humira, represents close to half of the company's current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women's health. Click Here to get the full Stock Report for AbbVie Inc stock.